Ken Griffin Eli Lilly & CO Transaction History

Citadel Advisors LLC

$509 Billion
Q1 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Eli Lilly & CO stock. As of the latest transaction made, Citadel Advisors LLC holds 1,728,700 shares of LLY stock, worth $1.56 Billion. This represents 0.26% of its overall portfolio holdings.

Number of Shares

1,728,700

Previous 1,313,000 31.66%

Holding current value

$1.56 Billion

Previous $765 Million 75.71%

% of portfolio

0.26%

Previous 0.16%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$592.2 - $792.28 $473 Million - $633 Million	-798,919 Reduced 62.61%	477,113 $371 Million
Q4 2023 Feb 14, 2024	BUY	$525.19 - $619.13 $271 Million - $320 Million	516,239 Added 67.94%	1,276,032 $744 Million
Q3 2023 Nov 14, 2023	BUY	$434.7 - $599.3 $92.9 Million - $128 Million	213,671 Added 39.13%	759,793 $408 Million
Q2 2023 Aug 14, 2023	BUY	$350.74 - $468.98 $104 Million - $139 Million	296,101 Added 118.43%	546,122 $256 Million
Q1 2023 May 15, 2023	BUY	$310.63 - $364.82 $22.8 Million - $26.7 Million	73,307 Added 41.48%	250,021 $85.9 Million

Q4 2022 Feb 14, 2023	SELL	$321.55 - $374.67 $259 Million - $302 Million	-806,571 Reduced 82.03%	176,714 $64.6 Million
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $53.9 Million - $61.4 Million	-181,800 Reduced 15.6%	983,285 $318 Million
Q2 2022 Aug 15, 2022	BUY	$278.73 - $327.27 $313 Million - $368 Million	1,123,361 Added 2692.36%	1,165,085 $378 Million
Q1 2022 May 16, 2022	SELL	$234.69 - $291.66 $21.7 Million - $27 Million	-92,520 Reduced 68.92%	41,724 $11.9 Million
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $10.6 Million - $13.1 Million	47,019 Added 53.91%	134,244 $37.1 Million
Q3 2021 Nov 15, 2021	SELL	$221.6 - $272.71 $88.9 Million - $109 Million	-401,002 Reduced 82.13%	87,225 $20.2 Million
Q2 2021 Aug 16, 2021	BUY	$180.55 - $233.54 $68 Million - $87.9 Million	376,546 Added 337.16%	488,227 $112 Million
Q1 2021 May 17, 2021	SELL	$164.32 - $212.72 $331 Million - $428 Million	-2,013,741 Reduced 94.75%	111,681 $20.9 Million
Q4 2020 Feb 16, 2021	BUY	$130.46 - $172.63 $203 Million - $268 Million	1,554,906 Added 272.54%	2,125,422 $359 Million
Q3 2020 Nov 16, 2020	SELL	$146.22 - $169.13 $104 Million - $120 Million	-711,139 Reduced 55.49%	570,516 $84.4 Million
Q2 2020 Aug 14, 2020	BUY	$136.42 - $164.18 $173 Million - $209 Million	1,270,416 Added 11303.64%	1,281,655 $210 Million
Q1 2020 May 15, 2020	SELL	$119.05 - $147.35 $12 Million - $14.8 Million	-100,689 Reduced 89.96%	11,239 $1.56 Million
Q4 2019 Feb 14, 2020	SELL	$106.92 - $132.43 $23.9 Million - $29.6 Million	-223,548 Reduced 66.64%	111,928 $14.7 Million
Q3 2019 Nov 14, 2019	BUY	$106.79 - $116.16 $3.64 Million - $3.96 Million	34,070 Added 11.3%	335,476 $37.5 Million
Q2 2019 Aug 14, 2019	SELL	$110.79 - $129.32 $374 Million - $436 Million	-3,372,002 Reduced 91.79%	301,406 $33.4 Million
Q1 2019 May 15, 2019	BUY	$111.31 - $131.02 $368 Million - $433 Million	3,307,234 Added 903.19%	3,673,408 $0
Q4 2018 Feb 14, 2019	BUY	$105.9 - $118.64 $4.89 Million - $5.48 Million	46,164 Added 14.43%	366,174 $42.4 Million
Q3 2018 Nov 13, 2018	SELL	$85.86 - $107.31 $1.39 Million - $1.74 Million	-16,231 Reduced 4.83%	320,010 $0
Q2 2018 Aug 10, 2018	BUY	$75.7 - $86.88 $13.1 Million - $15 Million	172,940 Added 105.9%	336,241 $0
Q1 2018 May 11, 2018	BUY	$74.21 - $87.6 $9.88 Million - $11.7 Million	133,113 Added 440.95%	163,301 $12.6 Million
Q4 2017 Feb 09, 2018	SELL	$81.94 - $87.89 $7.13 Million - $7.65 Million	-87,004 Reduced 74.24%	30,188 $2.55 Million
Q3 2017 Nov 09, 2017	BUY	$77.07 - $85.54 $9.03 Million - $10 Million	117,192	117,192 $10 Million

Others Institutions Holding LLY

# of Institutions

3,718

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $860B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account